Lazard Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,506
| Closed | -$93K | – | 2347 |
|
|
2021
Q2 | $93K | Buy |
+2,506
| New | +$93K | ﹤0.01% | 1376 |
|
|
2020
Q4 | – | Sell |
-1,166
| Closed | -$20K | – | 2042 |
|
|
2020
Q3 | $20K | Sell |
1,166
-801
| -41% | -$13.7K | ﹤0.01% | 1422 |
|
|
2020
Q2 | $49K | Buy |
+1,967
| New | +$49K | ﹤0.01% | 1235 |
|